I expect a delay of a few weeks. If that ends up t
Post# of 30027
I think, rather than knowing the results are positive, they still don't know the results. I do not agree with other posters on some other boards that these results are not required to be disclosed or immaterial just because they're interim.
I believe the company is hedging to make the Tollovir results release closer to Q4 results. If the results are good, then, bang bang. If they're bad, then revenue should stop the bleeding.
I have zero faith that the results of the tollovir trial would not leak out of the company once known. Therefore, with no substantial price change, I don't think they know it.